Brief: Hyperfine Announces Enrollment Of First Patient In Study To Expand Intended Use Of The Swoop® System With Contrast Agents
15/01/2026 13:17
Jan 15 (Reuters) - Hyperfine Inc HYPR.O: HYPERFINE ANNOUNCES ENROLLMENT OF FIRST PATIENT IN STUDY TO EXPAND INTENDED USE OF THE SWOOP® SYSTEM WITH CONTRAST AGENTS Source text: ID:nBw4hpNWKa Further company coverage: HYPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyperfine
See all newsBrief: Hyperfine Inc - Files To Register Up To 1.2 Million Shares Of Class A Common Stock By Selling Securityholders - SEC Filing
Hyperfine Q1 revenue rises as commercial engine accelerates
Brief: Hyperfine, Inc. Q1 EPS USD -0.09
Brief: Horizon Technology Finance Provides $40 Million Loan Facility To Hyperfine
Brief: Hyperfine Enters Loan And Security Agreement With Horizon Technology Finance - SEC Filing